Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$335M |
| 2 |
Amazon
AMZN
|
+$287M |
| 3 |
Otis Worldwide
OTIS
|
+$260M |
| 4 |
Alibaba
BABA
|
+$245M |
| 5 |
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$720M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$365M |
| 3 |
RTN
Raytheon Company
RTN
|
+$357M |
| 4 |
Schwab US Broad Market ETF
SCHB
|
+$212M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.87% |
| 2 | Healthcare | 13.57% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HCCI
2801
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $3.1M | ﹤0.01% |
177,738
-6,565
| -4% | -$111K |
|
|
BMY.RT
2802
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $3.1M | ﹤0.01% |
864,420
-56,958
| -6% | -$205K |
|
|
FONR
2803
DELISTED
Fonar
FONR
| $3.09M | ﹤0.01% |
144,486
+86,216
| +148% | +$1.76M |
|
2804
Greif Class B
GEF.B
$4.09B
| $3.08M | ﹤0.01% |
73,538
-3,095
| -4% | -$121K |
|
2805
Kewaunee Scientific
KEQU
$107M
| $3.07M | ﹤0.01% |
330,742
-488
| -0.1% | -$4.51K |
|
2806
Fulcrum Therapeutics
FULC
$286M
| $3.06M | ﹤0.01% |
167,473
+33,188
| +25% | +$523K |
|
2807
SunCoke Energy
SXC
$717M
| $3.06M | ﹤0.01% |
1,034,205
+68,314
| +7% | +$218K |
|
|
AKTS
2808
DELISTED
Akoustis Technologies Inc
AKTS
| $3.06M | ﹤0.01% |
369,366
+23,617
| +7% | +$183K |
|
|
ACBI
2809
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $3.05M | ﹤0.01% |
251,175
-3,082
| -1% | -$35.4K |
|
2810
Southern Missouri Bancorp
SMBC
$860M
| $3.05M | ﹤0.01% |
125,345
+34,611
| +38% | +$801K |
|
2811
SoundThinking
SSTI
$103M
| $3.04M | ﹤0.01% |
120,561
+19,721
| +20% | +$529K |
|
2812
BioLife Solutions
BLFS
$1.54B
| $3M | ﹤0.01% |
183,679
+46,391
| +34% | +$640K |
|
2813
SiTime
SITM
$17.5B
| $3M | ﹤0.01% |
63,321
+14,093
| +29% | +$418K |
|
|
MNK
2814
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $3M | ﹤0.01% |
1,119,852
+29,510
| +3% | +$88.5K |
|
|
VRAY
2815
DELISTED
ViewRay, Inc.
VRAY
| $3M | ﹤0.01% |
1,337,725
+73,998
| +6% | +$158K |
|
2816
eGain
EGAN
$198M
| $2.99M | ﹤0.01% |
269,219
+10,729
| +4% | +$97.6K |
|
|
MSON
2817
DELISTED
Misonix Inc
MSON
| $2.98M | ﹤0.01% |
219,658
+60,812
| +38% | +$743K |
|
2818
iShares MSCI ACWI ex US ETF
ACWX
$11.7B
| $2.98M | ﹤0.01% |
68,884
-291,897
| -81% | -$11.9M |
|
2819
Wave Life Sciences
WVE
$1.14B
| $2.97M | ﹤0.01% |
285,687
+154
| +0.1% | +$1.45K |
|
2820
Alphatec Holdings
ATEC
$1.57B
| $2.97M | ﹤0.01% |
632,660
+97,377
| +18% | +$430K |
|
|
PRVB
2821
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $2.96M | ﹤0.01% |
210,051
+138,823
| +195% | +$1.75M |
|
2822
CRISPR Therapeutics
CRSP
$5.13B
| $2.94M | ﹤0.01% |
40,069
+3,976
| +11% | +$232K |
|
|
KALV
2823
DELISTED
KalVista Pharmaceuticals
KALV
| $2.93M | ﹤0.01% |
242,193
+52,910
| +28% | +$563K |
|
|
CBMG
2824
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $2.92M | ﹤0.01% |
195,281
+27,894
| +17% | +$398K |
|
|
FPI
2825
Farmland Partners
FPI
$417M
| $2.92M | ﹤0.01% |
426,571
+93,117
| +28% | +$611K |
|
Similar funds
Northern Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Northern Trust held 4,386 positions worth $422B, up 21% from $348B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Northern Trust's Q2 2020 filing shows 169 new, 2,281 increased, 1,710 reduced and 126 closed positions. Its largest new stake was Otis Worldwide: 5,015,118 shares worth $285M. The largest sale was Allergan plc, an estimated $720M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q2 2020 buy was Otis Worldwide: 5,015,118 shares worth $285M.
- Northern Trust added most to AbbVie in Q2 2020, an estimated $335M increase.
- Northern Trust's biggest Q2 2020 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $365M.
- Northern Trust fully exited Allergan plc in Q2 2020, selling an estimated $720M.
- Northern Trust's ten largest holdings make up 21% of its $422B portfolio in Q2 2020.
- Northern Trust opened 169 new positions and closed 126 in Q2 2020.
- Northern Trust's portfolio value rose 21% quarter-over-quarter to $422B.
Based on Northern Trust's 13F filing for Q2 2020, filed 14 Aug 2020.